The Effect of Dimethicon On Prevention Of Ileus In Patients Suffering From Pelvic and Femoral Fractures A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200708048064N1

Enrollment

110

Registered

2020-11-23

Start date

2020-11-30

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileus In Hip and femoral fracture Patients. Paralytic ileus

Interventions

Intervention 1: Intervention group: Dimethicone 40 mg Pills will be given to the Intervention group three times a day and it will be consumed from the point of admission in hospital. So far, no study

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients with different types of pelvic and femoral fractures who were admitted to Madani Hospital for at least 3 days and treated during the study.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patients will be excluded if they have symptoms of ileus or take prokinetic drugs before surgery.

Design outcomes

Primary

Measure	Time frame
Determining Incidence rate of Ileus in patients receiving dimethicone. Timepoint: From the onset of admission in ward. Method of measurement: Patient History - Clinical Examination.	—

Secondary

Measure	Time frame
Comparison of gas passage time between intervention and control groups. Timepoint: From hospitalization until gas passage during hospitalization. Method of measurement: Patient history.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHaleh paak

Karaj University of Medical Sciences

halehpak80.md@gmail.com+98 26 3250 8967

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026